To ensure the safety of high-dose chemotherapy and autologous stem cell transplantation
(HDC/ASCT), evidence-based recommendations on infectious complications after …

Diagnosis and management of encephalitis is challenging in immunocompromised
individuals, in part because of atypical clinical presentations and the presence of uncommon …

Viral encephalitis is a rare but serious complication after hematopoietic cell transplantation
(HCT). The nonspecific early signs and symptoms and rapid progression can make it difficult …

Several studies have indicated that viral reactivations following allogeneic hematopoietic
stem cell transplantation (allo‐HSCT) are frequent, but viral reactivations after autologous …

Background Cytomegalovirus reactivation is often diagnosed in allogeneic hematopoietic
cell transplant recipients and therefore could lead to CMV-related disease, involving many …

Objectives We report the biological and clinical impacts possibly associated with HHV-6
reactivation in autologous hematopoietic stem cell transplant (AHSCT) recipients after …

Background Immunocompromised patients face reactivation of latent viruses that increase
the risk of morbidity. Aim The study aimed to detect human herpes virus 6 (HHV-6) …

Data regarding presentation and management of human herpes virus 6 (HHV-6) reactivation
among autologous hematopoietic cell transplantation (HCT) recipients are limited. We …

Reactivation of latent human herpesvirus 6 (HHV-6) is common after allogeneic
hematopoietic cell transplantation (HCT; transplantation of bone marrow, peripheral blood …

Abstract The monitoring of Human Herpesvirus 6 (HHV-6) after allogeneic stem cell
transplantation has proven to be useful in preventing life-threatening complications; …